(株)カイオム・バイオサイエンスの貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4583/E26096Chiome Bioscience Inc.
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2014/03/20日証協無担保0株0%0株0%100,455株+4.91%
2014/03/20日証協有担保1,030,360株+1.49%44,700株+7.97%542,600株+9.79%
2014/03/14日証協無担保0株0%0株0%95,749株+1.72%
2014/03/14日証協有担保1,015,260株-1.92%41,400株-49.2%494,200株+4.26%
2014/03/07日証協無担保0株0%0株-100%94,132株+1.09%
2014/03/07日証協有担保1,035,160株-12.22%81,500株+4.49%474,000株-12.45%
2014/02/28日証協無担保0株0%400株0%93,120株-7.89%
2014/02/28日証協有担保1,179,260株+6.8%78,000株+15.9%541,400株+3.94%
2014/02/21日証協無担保0株0%0株0%101,098株-35.12%
2014/02/21日証協有担保1,104,152株+18.08%67,300株+16.44%520,900株+17.29%
2014/02/14日証協無担保0株0%0株0%155,817株-4.46%
2014/02/14日証協有担保935,080株+10.34%57,800株+5.67%444,100株+11.85%
2014/02/07日証協無担保0株-100%0株0%163,087株+46.33%
2014/02/07日証協有担保847,440株-4.35%54,700株-4.2%397,060株-8.57%
2014/01/31日証協無担保1,400株0%0株0%111,449株+2.03%
2014/01/31日証協有担保886,012株+25.07%57,100株+10.23%434,260株+28.52%
2014/01/24日証協無担保0株0%0株0%109,229株+7.37%
2014/01/24日証協有担保708,392株+8.3%51,800株+83.04%337,900株+8%
2014/01/17日証協無担保0株0%0株0%101,729株+2.01%
2014/01/17日証協有担保654,092株-0.11%28,300株-5.98%312,872株+2.02%
2014/01/10日証協無担保0株-100%0株0%99,729株+7.78%
2014/01/10日証協有担保654,792株-8.68%30,100株-59.54%306,672株+0.52%
2013/12/30日証協無担保23,000株-5.35%0株0%92,528株+0.22%
2013/12/30日証協有担保716,992株-0.42%74,400株+178.65%305,072株-13.96%
2013/12/27日証協無担保24,300株+7.52%0株0%92,322株-1.38%
2013/12/27日証協有担保719,992株+2.17%26,700株+12.15%354,572株-1.36%
2013/12/20日証協無担保22,600株+927.27%0株0%93,613株+0.65%
2013/12/20日証協有担保704,700株+17.61%23,808株+41.65%359,472株+16.99%
2013/12/13日証協無担保2,200株-15.38%0株0%93,013株+0.43%
2013/12/13日証協有担保599,200株+2.18%16,808株-21.12%307,272株+4.74%
2013/12/06日証協無担保2,600株0%0株0%92,613株+0.97%
2013/12/06日証協有担保586,400株-3.81%21,308株-66.86%293,372株+6.42%
2013/11/29日証協無担保0株0%0株0%91,723株-6.82%
2013/11/29日証協有担保609,600株-6.67%64,300株+0.16%275,672株-7.05%
2013/11/22日証協無担保0株-100%0株0%98,433株-0.2%
2013/11/22日証協有担保653,200株-3.97%64,200株+0.94%296,572株-5.3%
2013/11/15日証協無担保4,900株0%0株0%98,632株+1.24%
2013/11/15日証協有担保680,200株+0.41%63,600株+2.75%313,172株+0.22%

※株式分割は考慮していませんのでご注意ください。

Page Top